“Quotas tend to be high and management will pip you if you miss quota twice.”
Really? This is the problem with most modern pharmaceutical and biotech companies. managed care dictates everything as does access. As time goes on both continue to be ridiculously challenging. Organizations need to reevaluate how they do business…just pay reps less that’s fine. Just make quotas as realistic and subject to the modern environment that we currently live in